2m 2m 2m 2m 2m 2m 2m
Bio-Rad Lab-A (BIO)
NYSE
$271.03-$10.08 (-3.59%)
Price as of Jun 23, 2026 5:39 PM EDT- $6.1BMarket Cap
- 19.35%1-Year Change
- Medical DevicesIndustry
Bio-Rad Lab-A (BIO)
$271.03-$10.08 (-3.59%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.6B +0.65% | 2.6B -3.92% | 2.7B -4.67% | 2.8B -4.12% | |
Cost of Revenue | 1.2B +4.69% | 1.2B -4.56% | 1.2B +0.76% | 1.2B -3.66% | |
Gross Profit | 1.3B -2.83% | 1.4B -3.37% | 1.4B -8.96% | 1.6B -4.47% | |
Sales and Marketing Expense | 844.3M +3.72% | 814.0M -3.29% | 841.7M +1.68% | 827.8M -5.88% | |
Research and Development Expense | -275.6M -6.86% | -295.9M +19.59% | -247.4M -3.68% | -256.9M -5.44% | |
Depreciation and Amortization Expense | 23.8M +12.26% | 21.2M -10.92% | 23.8M -4.42% | 24.9M -12.32% | |
Total Operating Expenses | 1.2B +4.69% | 1.2B -4.56% | 1.2B +0.76% | 1.2B -3.66% | |
Operating Profit | 47.2M -82.45% | 269.0M -20.37% | 337.8M -30.01% | 482.6M -1.39% | |
Interest Income | 95.5M +16.46% | 82.0M -18.73% | 100.9M +73.97% | 58.0M +206.88% | |
Interest Expense | -49.0M +0.20% | -48.9M -1.09% | -49.4M +29.71% | -38.1M +2,357.38% | |
Interest Income and Expense and Net | 46.5M +40.48% | 33.1M -35.68% | 51.5M +158.78% | 19.9M +14.62% | |
Total Nonoperating Income and Expense | 90.3M 0.00% | 90.3M -15.17% | 106.4M +138.80% | 44.6M +66.48% | |
Income before Taxes | 995.5M +142.50% | -2.3B +175.55% | -850.1M -81.93% | -4.7B -186.51% | |
Income Taxes | 235.6M +147.28% | -498.3M +134.19% | -212.8M -80.24% | -1.1B -190.31% | |
Extraordinary Items | 172.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 759.9M +141.20% | -1.8B +189.37% | -637.3M -82.43% | -3.6B -185.44% | |
Net Income from Continuing Operations Applicable to Common | 995.5M +142.50% | -2.3B +175.55% | -850.1M -81.93% | -4.7B -186.51% | |
Basic EPS and Net Income | 27.87 +142.64% | -65.36 +199.54% | -21.82 -82.08% | -121.79 -185.57% | |
Diluted EPS and Net Income | 27.85 +142.61% | -65.36 +199.54% | -21.82 -82.08% | -121.79 -186.65% | |
Basic Weighted Average Shares | 27.3M -3.37% | 28.2M -3.41% | 29.2M -1.93% | 29.8M -0.15% | |
Diluted Weighted Average Shares | 27.3M -3.31% | 28.2M -3.41% | 29.2M -1.93% | 29.8M -1.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 529.8M +8.54% | 488.1M +20.87% | 403.8M -7.00% | 434.2M -7.77% | |
Short-Term Investments | 1.0B -14.07% | 1.2B -2.24% | 1.2B -11.29% | 1.4B +239.85% | |
Cash and Cash Equivalents and Short-Term Investments | 1.5B -7.44% | 1.7B +3.57% | 1.6B -10.25% | 1.8B +105.84% | |
Total Current Assets | 2.9B -4.10% | 3.0B -0.59% | 3.0B -3.47% | 3.2B +58.77% | |
Accumulated Depreciation | 1.3B +13.69% | 1.1B +3.98% | 1.1B +5.68% | 1.0B +1.18% | |
Property and Plant and Equipment and Net | 539.9M +2.23% | 528.1M -0.17% | 529.0M +6.10% | 498.6M +1.56% | |
Total Long-Term Assets | 102.7M +0.79% | 101.9M +7.43% | 94.8M +0.27% | 94.6M -7.86% | |
Total Assets | 10.6B +12.95% | 9.4B -23.86% | 12.3B -8.91% | 13.5B -24.04% | |
Income Taxes Payable | 1.1B +29.06% | 849.2M -43.81% | 1.5B -16.18% | 1.8B -41.94% | |
Total Short-Term Debt | 1.3M +8.33% | 1.2M +146.91% | 486,000 +4.52% | 465,000 -4.91% | |
Total Current Liabilities | 517.0M +10.52% | 467.8M -10.52% | 522.8M -8.07% | 568.7M -16.48% | |
Total Long-Term Debt | 1.2B +0.11% | 1.2B +0.11% | 1.2B +0.11% | 1.2B +11,291.63% | |
Total Long-Term Liabilities | 199.1M +12.36% | 177.2M -9.18% | 195.1M -0.41% | 195.9M +7.53% | |
Total Liabilities | 3.1B +11.74% | 2.8B -21.45% | 3.6B -8.45% | 3.9B -5.41% | |
Retained Earnings | 8.2B +10.25% | 7.4B -19.91% | 9.3B -6.44% | 9.9B -26.72% | |
Total Stockholders Equity | 7.5B +13.46% | 6.6B -24.85% | 8.7B -9.09% | 9.6B -29.65% | |
Total Shares Outstanding | 21.9M -21.73% | 28.0M -1.78% | 28.5M -3.64% | 29.6M -1.12% | |
Cash Flow | |||||
Cash from Operating Activities | 532.2M +16.92% | 455.2M +21.41% | 374.9M +92.83% | 194.4M -70.38% | |
Capital Expenditures | 157.6M -4.83% | 165.6M +5.69% | 156.7M +38.92% | 112.8M -6.64% | |
Cash from Investing Activities | -189.7M +18.41% | -160.2M -892.76% | 20.2M +101.67% | -1.2B +53.94% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -283.2M +29.43% | -218.8M -48.60% | -425.6M -143.72% | 973.6M +1,856.44% | |
Financials Ratio | |||||
Gross Margin | 51.87% -3.46% | 53.73% +0.58% | 53.42% -4.49% | 55.93% -0.37% | |
Operating Margin | 1.83% -82.57% | 10.48% -17.12% | 12.65% -26.58% | 17.22% +2.84% | |
Return on Assets | 7.62% +144.76% | -17.03% +244.63% | -4.94% -78.70% | -23.20% -183.99% | |
Return on Equity | 10.84% +144.99% | -24.09% +246.93% | -6.94% -77.72% | -31.16% -186.41% | |
Revenue Growth | 0.65% +116.59% | -3.92% -16.10% | -4.67% +13.56% | -4.12% -127.80% | |
Current Ratio | 5.62 -13.22% | 6.48 +11.10% | 5.83 +5.00% | 5.55 +90.10% | |
Cash Ratio | 1.02 -1.78% | 1.04 +35.09% | 0.77 +1.17% | 0.76 +10.43% | |
Debt-to-Equity Ratio | 0.16 -11.76% | 0.18 +33.31% | 0.14 +10.11% | 0.12 +15,475.00% | |
Debt-to-Assets Ratio | 0.11 -11.38% | 0.13 +31.59% | 0.10 +9.92% | 0.09 +14,683.33% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow